Unbiased discovery-driven quantitative proteomics was performed to profile expression changes and degenerative modifications in the temporal lobe proteome (BA21) of AD+CVD patients compared to normal age-matched controls.
Data Dependent acquisition of 0.5-1ug nuclear extract generated from post-mortem frozen temporal cortex tissue (BA21/22) obtained from control or Dementia with Lewy body case.
